(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FINECARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

FINECARE

ST13

US500000079194964

Class

5, 10

Filing

79194964

Registration

5288241

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

05/31/2025

Trademark type

Combined

Nice classes

5, 10

Filing date

07/18/2016

Registration date

09/19/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/05/2024

Last transaction

05/31/2025

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

CN

Examiner

SEVERSON, KAREN

Law office

M80

Mark description

The mark consists of the wording "FINECARE" in stylized font with two diagonal diamond shapes above the letter "I".

Holders and representatives

Holders

G. W. (pessoa física)
GUANGZHOU WONDFO BIOTECH CO., LTD.
GUANGZHOU WONDFO BIOTECH CO., LTD.

Representatives

Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, PC

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of diabetes and skin conditions; chemical preparations for medical purposesdiagnosis of pregnancy; chemical preparations for sanitary purposes; chemical preparations for pharmaceutical or medical purposesfor the treatment of cancerdiabetes and skin conditions; cultures of microorganisms for medical or veterinary use; biological preparations for medical purposes for the treatment of cancerdiabetes and skin conditions; chemical preparations for pharmaceutical purposes for the treatment of respiratory infections; chemical preparations for medical purposes for the treatment of immune system diseases; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes

Class 10

Nursing appliancesnursing bottlesbreast pumps; blood testing apparatus; medical apparatus and instruments for use in treating cardiovascular disease; testing apparatus for medical purposeseye testing apparatus; immunochemical testing apparatus for medical use; organoleptic diagnostic testing apparatus for medical; apparatus for use in medical analysis for monitoring oxymetoryvital signs and blood properties; fumigation apparatus for medical purposes; medical apparatusspirometers; thermometers for medical purposes; diagnostic apparatus for medical purposesthe ultrasonic medical diagnostic apparatus; medical diagnostic apparatus for detection of cancerinflammationneoplasminfectious diseasesexually transmitted diseasediabeteskidney diseases and narcotic drugs ; arterial blood pressure measuring apparatus

Publications

History of USPTO decisions and trademark events.

31 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

05/29/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

01/04/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

11/24/2024

XXCR

GENERIC MADRID TRANSACTION CREATED

11/24/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

11/06/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

03/05/2024

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

03/05/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/04/2024

ES71

TEAS SECTION 71 RECEIVED

06/26/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/05/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/01/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/23/2018

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

01/07/2018

XXCR

GENERIC MADRID TRANSACTION CREATED

01/06/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/19/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

09/19/2017

PUBO

PUBLISHED FOR OPPOSITION

07/04/2017

NPUB

NOTICE OF PUBLICATION

06/14/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/23/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/03/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/03/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/03/2017

RFNT

REFUSAL PROCESSED BY IB

11/25/2016

MAFR

APPLICATION FILING RECEIPT MAILED

11/05/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/04/2016

RFRR

REFUSAL PROCESSED BY MPU

11/04/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/03/2016

CNRT

NON-FINAL ACTION WRITTEN

11/02/2016

DOCK

ASSIGNED TO EXAMINER

11/02/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/01/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/27/2016

Continuous trademark protection

Get notified about every new filing that threatens FINECARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.